DOI: 10.1055/s-00033990

TH Open

The 10 most popular articles of the last 3 months.

1
Gris, Jean-Christophe; Aoun, Joseph; Rzaguliyeva, Leyla; Begum, Rowshan; Salah, Hassan; Tugushi, Tatia; Ghani-Chabouk, Mohammed; Zibdeh, Mazen; Jassar, Waleed Al; Abboud, Joe; Meziane, Nadia; Ajayi, Godwin-Olufemi; Hossain, Nazli; Pyregov, Alexey; Abduljabbar, Hassan; Snyman, Leon C.; Rachdi, Radhouane; Tahlak, Muna-Abdulrazzaq; Najmutdinova, Dilbar; the SAVE Study Group: Risk Assessment and Management of Venous Thromboembolism in Women during Pregnancy and Puerperium (SAVE): An International, Cross-sectional Study
2
Cano, Stefan; Mantovani, Lorenzo; Folkerts, Kerstin; Gebel, Martin; Sahin, Kurtulus; Zell, Elizabeth; Monje, Danja; Schneider, Jonas; Eickels, Martin van; Haas, Sylvia; Kreutz, Reinhold; Ageno, Walter; Turpie, Alexander G. G.: Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis
3
Noguchi-Sasaki, Mariko; Soeda, Tetsuhiro; Ueyama, Atsunori; Muto, Atsushi; Hirata, Michinori; Kitamura, Hidetomo; Fujimoto-Ouchi, Kaori; Kawabe, Yoshiki; Nogami, Keiji; Shima, Midori; Kitazawa, Takehisa: Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro
4
Ruiz-Artacho, Pedro; Trujillo-Santos, Javier; López-Jiménez, Luciano; Font, Carme; Díaz-Pedroche, María del Carmen; Sánchez Muñoz-Torrero, Juan Francisco; Peris, Maria Luisa; Skride, Andris; Maestre, Ana; Monreal, Manuel; the RIETE Investigators: Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism
5
Kim, Paul Y.; Yeh, Calvin H.; Dale, Brian J.; Leslie, Beverly A.; Stafford, Alan R.; Fredenburgh, James C.; Hirsh, Jack; Weitz, Jeffrey I.: Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation
6
Favresse, Julien; Lardinois, Benjamin; Sabor, Lina; Devalet, Bérangère; Vandepapeliere, Julie; Braibant, Maximilien; Lessire, Sarah; Chatelain, Bernard; Jacqmin, Hugues; Douxfils, Jonathan; Mullier, François: Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests
7
Tafur, Alfonso J.; Fuentes, Harry; Caprini, Joseph A.; Rivas, Agustina; Uresandi, F.; Duce, Rita; Lopez-Reyes, Raquel; Visona, Adriana; Merah, Adel; Monreal, Manuel: Predictors of Early Mortality in Cancer-Associated Thrombosis: Analysis of the RIETE Database
8
Gibson, C. Michael; Spyropoulos, Alex C.; Cohen, Alexander T.; Hull, Russell D.; Goldhaber, Samuel Z.; Yusen, Roger D.; Hernandez, Adrian F.; Korjian, Serge; Daaboul, Yazan; Gold, Alex; Harrington, Robert A.; Chi, Gerald: The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification
9
Ageno, Walter; Mantovani, Lorenzo G.; Haas, Sylvia; Kreutz, Reinhold; Monje, Danja; Schneider, Jonas; van Eickels, Martin; Gebel, Martin; Turpie, Alexander G. G.: Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE
10
Gade, Inger Lise; Brækkan, Sigrid K.; Næss, Inger Anne; Hansen, John-Bjarne; Cannegieter, Suzanne C.; Rosendaal, Frits R.; Overvad, Kim; Hindberg, Kristian; Hammerstrøm, Jens; Gran, Olga V.; Tjønneland, Anne; Severinsen, Marianne T.; Kristensen, Søren R.: Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort